爱博医疗 (688050.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

20.7x

EV/EBITDA

17.7x

Market Cap

CNY 7.59B

MomentumView details →

1D Return

−3.11%

YTD Return

—

RSI (14)

43.5

ValuationView details →

P/E (Fwd)

20.7x

EV/EBITDA

17.7x

Market Cap

CNY 7.59B

RSI (14)

43.5

MomentumView details →

1D Return

−3.11%

YTD Return

—

ProfitabilityView details →

Gross Margin

62.71%

Net Margin

17.38%

EBITDA Margin

30.30%

ROE (TTM)

9.25%

ROA (TTM)

5.56%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

+4.60%

EPS YoY

−31.01%

FCF YoY

+95.85%

Revenue CAGR 3Y

+36.77%

EPS CAGR 3Y

−14.12%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.48

EPS Surprise

0.77%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.48

Avg Surprise (4Q)

0.77%

Rev Surprise

−4.30%

Capital & dividendView details →

Debt/Equity

0.34x

Current Ratio

3.11x

Quick Ratio

2.47x

Div Yield

0.81%

Div Rate

CNY 0.32

Div Growth 1Y

−8.57%

Financials snapshotView financials →

Revenue (TTM)

1.52B

Net Income (TTM)

264.89M

Op. CF (TTM)

312.35M

Next earningsOct 22, 2026 →

Latest newsMore news →

Eyebright Medical Technology released its 2026 semi-annual report, with first-half revenue up 18.57% year-on-year and net profit down 14.39% year-on-year.10d ago

Similar companies

Modern Dental Group Limited03600.HK AptarGroup, Inc.ATR 天智航-U688277.SH 圣湘生物688289.SH Bausch + Lomb CorporationBLCO Masimo CorporationMASI Find similar companies →

Latest newsMore news →

Eyebright Medical Technology released its 2026 semi-annual report, with first-half revenue up 18.57% year-on-year and net profit down 14.39% year-on-year.10d ago